1. NCHU Institution Repository
  2. 農業暨自然資源學院
  3. 食品暨應用生物科技學系
Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/90258
標題: 發展環境友善型食品級乳酸鏈球菌之腸病毒71型口服疫苗並評估對BALB/c小鼠之免疫效果
Development of environment-friendly food grade Lactococcus lactis system as oral vaccine against EV71 and evaluation on the vaccination effect by BALB/c mice.
作者: 林惠婷
Huei-Ting Lin
關鍵字: Enterovirus 71;Gram-positive enhancer matrix (GEM);Recombinant VP1e anchor motif;recombinant VP1e (rVP1e);L. lactis expression system;Oral immunization;腸病毒71型;革蘭陽性加強介質(gram-positive enhancer matrix;GEM);重組VP1e anchor motif融合蛋白質 (rVP1e-anchor);重組 VP1e蛋白質 (rVP1e);乳酸菌表現系統;口服疫苗
引用: Asensi, G. F., et al. 2013 Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model. Microb Cell Fact 12:32. Avall-Jaaskelainen, S., et al. 2002 Surface display of foreign epitopes on the Lactobacillus brevis S-layer. Appl Environ Microbiol 68(12):5943-51. Bahey-El-Din, M. 2012 Lactococcus lactis-based vaccines from laboratory bench to human use: an overview. Vaccine 30(4):685-90. Bahey-El-Din, M., B. T. Griffin, and C. G. Gahan 2008 Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000. Microb Cell Fact 7:24. Berlec, A., et al. 2013 Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity. Appl Microbiol Biotechnol 97(10):4333-42. Bermudez-Humaran, L. G., et al. 2004 An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol 53(Pt 5):427-33. Brown, B. A., et al. 1999 Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73(12):9969-75. Carr, F. J., D. Chill, and N. Maida 2002 The lactic acid bacteria: a literature survey. Crit Rev Microbiol 28(4):281-370. Chart, H., et al. 2000 An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5alpha and EQ1. J Appl Microbiol 89(6):1048-58. de Veer, M., and E. Meeusen 2011 New developments in vaccine research--unveiling the secret of vaccine adjuvants. Discov Med 12(64):195-204. de Vos, W. M., M. Kleerebezem, and O. P. Kuipers 1997 Expression systems for industrial Gram-positive bacteria with low guanine and cytosine content. Curr Opin Biotechnol 8(5):547-53. de Vos, W. M., et al. 1995 Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria. Mol Microbiol 17(3):427-37. De Vuyst, L., and F. Leroy 2007 Bacteriocins from lactic acid bacteria: production, purification, and food applications. J Mol Microbiol Biotechnol 13(4):194-9. Desvaux, M., et al. 2006 Protein cell surface display in Gram-positive bacteria: from single protein to macromolecular protein structure. FEMS Microbiol Lett 256(1):1-15. Dieye, Y., et al. 2001 Design of a protein-targeting system for lactic acid bacteria. J Bacteriol 183(14):4157-66. Engelhardt, H., and J. Peters 1998 Structural research on surface layers: a focus on stability, surface layer homology domains, and surface layer-cell wall interactions. J Struct Biol 124(2-3):276-302. Gasson, M. J. 1983 Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154(1):1-9. Gilliland, S. E. 1990 Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev 7(1-2):175-88. Goldsby, R.A., Kindt, T.J., Osborne, B.A., and Kuby, J. 2003.　Immunology, Fifth Edition, WH Freeman and Company, New York.　Holmgren, J. and Czerkinsky, C. 2005. Mucosal immunity and　vaccines. Nat. Med. 11: 45-53. Haneberg, B., et al. 1994 Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun 62(1):15-23. Holmgren, J., and C. Czerkinsky 2005 Mucosal immunity and vaccines. Nat Med 11(4 Suppl):S45-53. Hugenholtz, J., et al. 2002 Metabolic engineering of lactic acid bacteria for the production of nutraceuticals. Antonie Van Leeuwenhoek 82(1-4):217-35. Kunji, E. R., D. J. Slotboom, and B. Poolman 2003 Lactococcus lactis as host for overproduction of functional membrane proteins. Biochim Biophys Acta 1610(1):97-108. Le Loir, Y., et al. 2005 Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production. Microb Cell Fact 4(1):2. Lee, S. Y., J. H. Choi, and Z. Xu 2003 Microbial cell-surface display. Trends Biotechnol 21(1):45-52. Leenhouts, K., G. Buist, and J. Kok 1999 Anchoring of proteins to lactic acid bacteria. Antonie Van Leeuwenhoek 76(1-4):367-76. Madsen, S. M., et al. 1999 Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32(1):75-87. Melnick, J. L. 1984 Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis 6 Suppl 2:S387-90. Melnick, J. L., I. Tagaya, and H. von Magnus 1974 Enteroviruses 69, 70, and 71. Intervirology 4(6):369-70. Mierau, I., et al. 2005 Optimization of the Lactococcus lactis nisin-controlled gene expression system NICE for industrial applications. Microb Cell Fact 4:16. Morello, E., et al. 2008 Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 14(1-3):48-58. Petsch, D., and F. B. Anspach 2000 Endotoxin removal from protein solutions. J Biotechnol 76(2-3):97-119. Qin, J., et al. 2014 Construction of a food-grade cell surface display system for Lactobacillus casei. Microbiol Res. Raha, A. R., et al. 2005 Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biotechnol 68(1):75-81. Ravnikar, M., et al. 2010 Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and tumor necrosis factor alpha. Appl Environ Microbiol 76(20):6928-32. Reed L. J. and Muench H. 1938 A simple method of estimating fifty percent endpoints. Amer. J. Hyg. 27, 493–497. Ribeiro, L. A., et al. 2002 Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microbiol 68(2):910-6. Sanders, M. E., and J. Huis in't Veld 1999 Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues. Antonie Van Leeuwenhoek 76(1-4):293-315. Sleytr, U. B., and M. Sara 1997 Bacterial and archaeal S-layer proteins: structure-function relationships and their biotechnological applications. Trends Biotechnol 15(1):20-6. Sleytr, Uwe B. 1997 I. Basic and applied S-layer research: an overview1. FEMS Microbiology Reviews 20(1-2):5-12. Smith, G. P. 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228(4705):1315-7. Sorensen, H. P., and K. K. Mortensen 2005 Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 115(2):113-28. Studier, F. W. 1991 Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J Mol Biol 219(1):37-44. Studier, F. W., and B. A. Moffatt 1986 Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189(1):113-30. Terpe, K. 2006 Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72(2):211-22. van Klompenburg, W., et al. 1998 Phosphatidylethanolamine mediates insertion of the catalytic domain of leader peptidase in membranes. FEBS Lett 431(1):75-9. van Roosmalen, M. L., et al. 2006 Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38(2):144-9. Varma, N. R., et al. 2013 Display of the Viral Epitopes on Lactococcus lactis: A Model for Food Grade Vaccine against EV71. Biotechnol Res Int 2013:431315. Wells, J. M., and A. Mercenier 2008 Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6(5):349-62. Welman, A. D., and I. S. Maddox 2003 Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends Biotechnol 21(6):269-74. Wieczorek, A. S., and V. J. Martin 2010 Engineering the cell surface display of cohesins for assembly of cellulosome-inspired enzyme complexes on Lactococcus lactis. Microb Cell Fact 9:69. University of Helsinki Faculty of Science Department of Biosciences Division of Biochemistry Helsinki, Finland The VP1 intracapsid hook and uncoating of enteroviruses by Antero Airaksinen Vero cell : http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3616b1a.pdf 林貴香（2000）．詭譎多變的腸病毒．大豐醫藥資訊，41（10），39－40。 邱婷芳、黃立民、李慶雲（1999）．腸病毒概論．台灣醫學，3（17），43－48。 張鑾英、林奏延、黃玉成、許光宏、鐘佩雲、康志銘（1999）．腸病毒71型重症之危險因子與致病機轉．台灣醫學，3（1），99－103。 蔣立琦（2000）．兒科護理學．台北：永大。 林志侯。乳酸菌載體表現系統之研究現況與趨勢。農業生技產業季刊。 周怡廷。2004。以菌體表層展示技術表現重組之表層蛋白及融合蛋白於大腸桿菌、乳酸桿菌及乳酸練球菌。國立中興大學食品暨應用生物科技學系碩士論文。 蘇政蕙。2005年。挑選持續型強力啟動子並表現重組抗凍蛋白類似物於乳酸鏈球菌與乳酸桿菌中。國立中興大學食品暨應用生物科技學系碩士論文。 彭宣融。2006年。開發重組乳酸鏈球菌口服疫苗。國立中興大學食品暨應用生物科技學系碩士論文。 黃馨慧。2007年。增進第一型重組抗凍蛋白質類似物於乳酸鏈球菌之分泌表現。國立中興大學食品暨應用生物科技學系碩士論文。 羅詩晴。2009年。以枯草桿菌分泌生產腸病毒71型VP1蛋白之部份表位片段及評估此表位片段對BALB/c小鼠之免疫效果。國立中興大學食品暨應用生物科技學系碩士論文。 吳柏彥。2010年。研究枯草桿菌xylose誘導型系統與以枯草桿菌生產融合廣效性流感病毒HA抗原之疫苗。國立中興大學食品暨應用生物科技學系碩士論文。 李珮瑄。2013年。環境友善型食品級乳球菌口服疫苗系統之研發。國立中興大學食品暨應用生物科技學系碩士論文。 行政院衛生署疾病管制局 http://www.cdc.gov.tw/
摘要: 
The Human enterovirus 71 causes hand, foot and mouth disease, especially in infants and young children. These outbreaks happened currently in the Asia-Pacific regions. So far, the effective EV71 vaccine is highly recommended. Human enterovirus 71 belongs to a genus of positive-sense single strand RNA virus. Capsid proteins of EV71 consist of VP1, VP2, VP3 and VP4. In the previous research, the VP1 capsid protein harbors the main neutralizing epitopes of EV71.
The use of a food grade organism that is noninvasive and nonpathogenic as antigen delivery vehicle is a promising vaccine strategy. Lactococcus lactis has long been used in food fermentation, and regarded as generally recognized as safe (GRAS) and food grade microorganisms. Killed L.lactis is suggested to be gram positive enhancer matrix (GEM) which enhances the vaccination as adjuvant.
In this study, the optimal GEM preparation conditions were established. Results showed that boiled the stationary phase L.lactis MG1363 in 0.125M lactic acid for 1 min obtained GEM. The recombinant VP1e-anchor motif (rVP1e-anchor) was expressed, purified and bound to GEM. The optimal binding condition was 400 μg recombinant protein to GEM under pH 2 buffer which achieved 4.17*1010 molecules/GEM cell.
The storage stabilities of rVP1e-anchor bound GEM were evaluated, and confirmed by microscopy analysis. The rVP1e-anchor bound GEM (rVP1e-GEM) was stable under 4 °C or -80°C storage.
For comparison, the recombinant VP1e-His tag protein (rVP1e-His tag) and recombinant VP1e (rVP1e) were expressed by L. lactis constitutive expression system. The secreted level of VP1e-His tag protein was much lower than rVP1e.
The vaccination effects of rVP1e-GEM by oral route and rVP1e by injection route were evaluated in animal trials.The specific antibody IgG 1, IgG 2a and cytokine IFN-γ, IL-4 were examined. As the results shown, the specific antibody and cytokine were induced after administered to BLAB/c mice. There are no significant difference between oral immunization groups and IP groups in the specific antibody, IgA. Results suggested that the rVP1e-anchor bound GEM can be seen as potent oral vaccine.
URI: http://hdl.handle.net/11455/90258
Rights: 同意授權瀏覽/列印電子全文服務，2018-08-18起公開。
Appears in Collections:食品暨應用生物科技學系

Files in This Item:
File SizeFormat Existing users please Login
nchu-104-7102043013-1.pdf3.54 MBAdobe PDFThis file is only available in the university internal network   
Show full item record
 
TAIR Related Article

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.